Cardinal Health, Inc. $CAH Stock: Valley National Advisers Inc. Grows Holdings

Key Points

• Valley National Advisers increased its Cardinal Health stake by 4,405% in the third quarter, bringing its holdings to 9,956 shares valued at approximately $2.2 million. Institutional investors collectively own 87.17% of the company.
• Analysts maintain a “Moderate Buy” consensus on Cardinal Health, with 16 Buy ratings and three Holds and an average price target of $269.38.
• Cardinal Health reported quarterly EPS of $2.91, beating estimates of $2.42, while revenue rose 5.8% year over year. The company also pays a quarterly dividend of $0.5158 per share, representing an annualized yield of approximately 0.8%.

Valley National Advisers Inc. raised its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 4,405.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,956 shares of the company's stock after buying an additional 9,735 shares during the period. Valley National Advisers Inc.'s holdings in Cardinal Health were worth $2,215,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in CAH. Signaturefd LLC raised its holdings in shares of Cardinal Health by 2.3% in the 3rd quarter. Signaturefd LLC now owns 3,437 shares of the company's stock worth $765,000 after acquiring an additional 77 shares during the last quarter. Simplicity Wealth LLC lifted its position in Cardinal Health by 10.7% in the 3rd quarter. Simplicity Wealth LLC now owns 2,263 shares of the company's stock valued at $504,000 after acquiring an additional 219 shares in the last quarter. Ascent Wealth Partners LLC lifted its position in Cardinal Health by 1.5% in the 3rd quarter. Ascent Wealth Partners LLC now owns 12,268 shares of the company's stock valued at $2,730,000 after acquiring an additional 186 shares in the last quarter. Gibbs Wealth Management lifted its position in Cardinal Health by 67.7% in the 3rd quarter. Gibbs Wealth Management now owns 2,156 shares of the company's stock valued at $480,000 after acquiring an additional 870 shares in the last quarter. Finally, XXI Wealth LLC boosted its stake in Cardinal Health by 14.7% during the 3rd quarter. XXI Wealth LLC now owns 4,291 shares of the company's stock valued at $955,000 after purchasing an additional 549 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Robert W. Baird boosted their price objective on Cardinal Health from $251.00 to $274.00 and gave the stock an "outperform" rating in a report on Wednesday, August 12th. Mizuho raised their target price on Cardinal Health from $250.00 to $280.00 and gave the company an "outperform" rating in a report on Tuesday, October 20th. JPMorgan Chase & Co. raised their target price on Cardinal Health from $215.00 to $260.00 and gave the company a "neutral" rating in a report on Thursday, August 13th. Morgan Stanley lifted their target price on Cardinal Health from $255.00 to $265.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Finally, Barclays upped their price target on Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a report on Thursday, August 13th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $269.38.

Cardinal Health Trading Down 2.4%

NYSE:CAH opened at $249.47 on Friday. The stock has a market capitalization of $57.77 billion, a PE ratio of 34.50, a price-to-earnings-growth ratio of 1.50 and a beta of 0.50. The firm's 50 day moving average is $236.46 and its 200 day moving average is $223.73. Cardinal Health, Inc. has a 12 month low of $158.70 and a 12 month high of $259.21.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The business had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter in the prior year, the business earned $2.08 earnings per share. Cardinal Health's revenue for the quarter was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Research analysts predict that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were paid a dividend of $0.5158 per share. The ex-dividend date was Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. Cardinal Health's dividend payout ratio is presently 28.49%.

Insider Activity at Cardinal Health

In related news, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the sale, the chief executive officer owned 77,901 shares of the company's stock, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Stephen Mason sold 35,000 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the sale, the chief executive officer directly owned 18,061 shares of the company's stock, valued at approximately $4,269,620.40. This trade represents a 65.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 210,271 shares of company stock worth $49,626,657 in the last three months. Corporate insiders own 0.12% of the company's stock.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.